Elevated Serum α-Synuclein Autoantibodies in Patients with Parkinson’s Disease Relative to Alzheimer’s Disease and Controls

Early diagnosis of neurodegenerative diseases is of paramount importance for successful treatment. Lack of sensitive and early biomarkers for diagnosis of diseases like Parkinson’s disease (PD) is a handicapping problem for all movement disorders specialists. Using serum autoimmune antibodies (AIAs)...

Descripción completa

Detalles Bibliográficos
Autores principales: Shalash, Ali, Salama, Mohamed, Makar, Marianne, Roushdy, Tamer, Elrassas, Hanan Hany, Mohamed, Wael, El-Balkimy, Mahmoud, Abou Donia, Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5744443/
https://www.ncbi.nlm.nih.gov/pubmed/29312137
http://dx.doi.org/10.3389/fneur.2017.00720

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5744443/
https://www.ncbi.nlm.nih.gov/pubmed/29312137
http://dx.doi.org/10.3389/fneur.2017.00720

Ejemplares similares